Methotrexate EP Impurity K (Folinic Acid EP Impurity A)
CAS: 4271-30-1
Ref. 4Z-M-7016
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
Methotrexate EP Impurity K (Folinic Acid EP Impurity A)
Synonyms:
- (4-aminobenzoyl)-L-glutamic acid
- (2R)-2-[(4-aminobenzoyl)amino]pentanedioic acid
- (2S)-2-[(4-Aminobenzoyl)amino]pentanedioic acid
- (4-Aminobenzoyl)-<span class="text-smallcaps">L</span>-glutamic acid
- (S)-2-(4-Aminobenzamido)pentanedioicacid
- (p-Aminobenzoyl)-<span class="text-smallcaps">L</span>-glutamic acid
- (p-Aminobenzoyl)glutamic acid
- <span class="text-smallcaps">L</span>-Glutamic acid, N-(4-aminobenzoyl)-
- Glutamic acid, N-(p-aminobenzoyl)-
- Glutamic acid, N-(p-aminobenzoyl)-, <span class="text-smallcaps">L</span>-
- See more synonyms
- N-(4-Aminobenzoyl)-<span class="text-smallcaps">L</span>-glutamic acid
- N-(4-Aminobenzoyl)-L-glutamic acid
- N-(p-Aminobenzoyl)-<span class="text-smallcaps">L</span>(+)-glutamic acid
- N-(p-Aminobenzoyl)glutamic acid
- NSC 71042
- P-Amino benzamide glutamic acid
- P-aminobenzamide glutamic acid
- Glutamic acid, N-(p-aminobenzoyl)-, L-
- N-(p-Aminobenzoyl)-L-glutamic acid
- L-Glutamic acid, N-(4-aminobenzoyl)-
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TLC
Long term storage:
Notes:
Chemical properties
Molecular weight:
266.25
Formula:
C12H14N2O5
Color/Form:
Light Brown Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 4Z-M-7016 Methotrexate EP Impurity K (Folinic Acid EP Impurity A)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
